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SmadLeft–right (L–R) asymmetry in themouse embryo is generated in the node and is dependent on cilia-driven ﬂuid
ﬂow, but how the initial asymmetry is transmitted from the node to the lateral plate has remained unknown.We
have now identiﬁed a transcriptional enhancer (ANE) in the human LEFTY1 gene that exhibits marked LNR
asymmetric activity in perinodal cells of the mouse embryo. Dissection of ANE revealed that it is activated in the
perinodal cells on the left side by Nodal signaling, suggesting that Nodal activity in the node is asymmetric at a
time when Nodal expression is symmetric. Phosphorylated Smad2/3 (pSmad2) indeed manifested an L–R
asymmetric distribution at the node, being detected in perinodal cells preferentially on the left side.
This asymmetry in pSmad2 distribution was found to be generated not by unidirectional transport of Nodal
but rather as a result of LbR asymmetric expression of the Nodal antagonist Cerl2. For various mutant embryos
examined, the asymmetry in pSmad2 distribution among the perinodal cells closelymatched that in lateral plate
mesoderm (LPM). However, autocrine–paracrine Nodal signaling in perinodal cells is dispensable for L–R
patterning of LPM, given that its inhibition by expression of dominant negative forms of Smad3 or ALK4was still
associated with normal (left-sided) Nodal expression in LPM. Our results suggest that LPM is the direct target of
Nodal secreted by the perinodal cells, and that an LNR distribution of active Nodal in the node is translated into
the asymmetry in LPM.s Group, Graduate School of
, Suita, Osaka 565-0871, Japan.
da).
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Visceral organs of vertebrates exhibit left–right (L–R) asymmetry in
their positions and morphology. The mechanism responsible for
generation of such L–R asymmetry is largely conserved among
vertebrates, although some diversity is apparent (Tabin, 2005). Four
steps are required to establish L–R asymmetric patterning in the mouse
embryo (Shiratori and Hamada, 2006): (1) symmetry breaking as a
result of the leftward ﬂow generated by rotational movement of
primary cilia in the node; (2) transmission of an asymmetric signal
(or signals) to lateral plate mesoderm (LPM); (3) asymmetric
expression of Nodal and Lefty2, which encodes a feedback inhibitor of
Nodal signaling, in the left LPM; and (4) situs-speciﬁc morphogenesis
mediated by asymmetric expression of Pitx2, which encodes a
transcription factor and is regulated by Nodal signaling. Despite recent
progress in characterization of this sequence of events, an importantissue that has remained unresolved concerns the mechanism by which
the asymmetric signal (or signals) is transferred from the node to LPM.
Nodal, a secretory protein that belongs to the transforming growth
factor-beta (TGF-beta) superfamily, plays a key role in signal transfer
from the node to LPM. Nodal is expressed bilaterally in the perinodal
cells (crown cells) before its asymmetric expressionbegins in LPM.Mice
speciﬁcally lacking Nodal expression in the node lose asymmetric gene
expression in LPM, suggesting that Nodal produced in the node is
essential for subsequent L–R patterning of LPM (Brennan et al., 2002;
Saijoh et al., 2003). Several lines of circumstantial evidence suggest that
Nodal protein (more precisely, the Nodal-GDF1 heterodimer) produced
in the node is directly transported to LPM. First, asymmetric expression
of Nodal and Lefty2 in LPM is regulated by a Nodal-responsive enhancer
that is designated ASE (Adachi et al., 1999; Norris and Robertson, 1999;
Saijoh et al., 2000). Second, GDF1 (growth-differentiation factor 1), a
co-ligand of Nodal that increases Nodal activity (Tanaka et al., 2007), is
coexpressed with Nodal in the perinodal cells and is also required for
asymmetric Nodal expression in LPM (Rankin et al., 2000). Third,
sulfated glycosaminoglycans present in the extracellular matrix
between the node and LPM bindNodal and are required for asymmetric
Nodal expression in LPM (Oki et al., 2007). Finally, Nodal ectopically
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Wright, 2011) embryos is able to diffuse over a long distance, such as
from LPM to the midline. However, direct evidence for the transport of
endogenous Nodal from the node to LPM has not been obtained to date,
most likely because of technical limitations. Even if Nodal is indeed
transported, however, it is unclear how it would be transported
preferentially to the left side.
An asymmetric signal must be generated in or near the node,
although its identity remains uncertain. The identiﬁcation of this
asymmetric signal and characterization of how it is transferred from
the node to LPM will require identiﬁcation of markers that show L–R
asymmetry on both sides at the node and elucidation of the molecular
mechanismsunderlying their asymmetry. Several genes, includingCerl2
(Marques et al., 2004), L-Plunc1 (Hou et al., 2004), and Ablim1 (Stevens
et al., 2010), exhibit L–R asymmetric expression in the node—or more
precisely, in the perinodal crown cells. However, the asymmetric
expression of these genes is often dynamic, making it difﬁcult to
examine the underlying molecular mechanisms. During our analysis of
transcriptional regulation of Nodal and Lefty genes, we noticed that
human LEFTY1 contains an enhancer that confers marked L–R
asymmetric expression in the node. We have now examined this
enhancer and have identiﬁed the signal that regulates its activity.
Materials and methods
Transgenes and mice
Various lacZ transgenes were constructed in the vector LEFTY1pro-
lacZ, which contains the LEFTY1 promoter linked to lacZ. A variety of test
fragmentswere individually subcloned into LEFTY1pro-lacZ at the5′ side
of the LEFTY1 promoter in a reverse orientation. The resulting lacZ
plasmidsweredigestedwith appropriate restrictionenzymes to remove
vector sequences, and the remaining vector sequence-free DNA
fragments were puriﬁed by gel electrophoresis and microinjected into
fertilized mouse eggs as described (Hogan et al., 1994; Saijoh et al.,
1999). Embryos were recovered at embryonic day (E) 8.2 or the
indicated developmental stages and were examined for the absence or
presence of the transgene by the polymerase chain reaction (PCR) and
for lacZ expression by staining with 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal) according to standard protocols. A perma-
nent mouse line harboring hNPE7.5-lacZ (line 20) was established as
described previously (Hogan et al., 1994); embryos derived from this
line showed X-gal staining patterns identical to those observed in
transient transgenic embryos. The hNPE7.5-lacZ transgene was trans-
ferred to various mutant backgrounds by mating of the permanent
transgenic mice with iv/iv (Supp et al., 1997), inv/+ (Yokoyama et al.,
1993), Nodalneo/+ (Saijoh et al., 2003), Cryptic+/− (Yan et al., 1999), or
Cerl2+/− (Marques et al., 2004) mice. The resulting mutant embryos
were genotyped by allele-speciﬁc PCRanalysis.Micewith aﬂoxed Foxh1
allele (Yamamoto et al., 2001) were also crossedwithmice that express
Cre recombinase speciﬁcally in perinodal cells (NDE-Cre mice) to
generate Foxh1 conditional mutant embryos (Foxh1ﬂox/ﬂox, NDE-Cre)
that lack FoxH1 speciﬁcally in the perinodal cells. Transgene that
expresses dominant-negative ALK4 (NDE-dnALK4-IRES-lacZ) or domi-
nant-negative Smad3 (NDE-dnSmad3-IRES-lacZ) contains two tandem
copies of the node-speciﬁc enhancer (NDE) and Hsp68 promoter linked
to either dnSmad3 or dnALK4, an internal ribosomeentry site (IRES), and
lacZ.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed according to
standard procedures (Wilkinson andNieto, 1993)withminormodiﬁca-
tions. For two-color detection, ﬂuorescein-labeled RNA probes were
detected with alkaline phosphatase-conjugated antibodies to ﬂuores-
cein and with the combination of 2-[4-iodophenyl]-3-[4-nitrophenyl]-5-phenyltetrazolium chloride and 5-bromo-4-chloro-3-indolyl phos-
phate (INT/BCIP) as a red substrate.
Immunostaining
Mouse embryos were recovered and ﬁxed from 2 h to overnight at
4 °C with 4% paraformaldehyde in phosphate-buffered saline (PBS).
They were then dehydrated with methanol and incubated for 1 h at
room temperature with 3% H2O2 in methanol. After rehydration with
PBS containing 0.1% Triton X–100, they were incubated with blocking
buffer [BB: 0.5% TSA Blocking Reagent (Perkin Elmer), 0.1 M Tris–HCl
(pH7.5), 0.15 MNaCl] beforeexposure to rabbit polyclonal antibodies to
phosphorylated Smad2/3 (pSmad2) that can detect Smad3 phosphor-
ylated at Ser465 and Ser467, and may detect phosphorylated Smad3 at
its equivalent site (Cell Signaling Technology, #3101) or chicken
polyclonal antibodies to beta-galactosidase (Abcam, ab9361) at dilu-
tions of 1:50 and 1:500 in BB, respectively. Immune complexes for
pSmad2 were detected with biotinylated goat antibodies to rabbit
immunoglobulinG (Vector) at a dilution of 1:200 inBB, aVectastainABC
Kit (Vector), and Fluorophore Tyramide Working Solution (Perkin
Elmer). Immune complexes for beta-galactosidase were detected with
Alexa Fluor 633-conjugated goat antibodies to chicken immunoglobulin
G (Molecular Probes) at a dilution of 1:500 in BB.
Whole-embryo culture
Whole embryos were cultured essentially as described previously
(Yamamoto et al., 2003). E8.0 mouse embryos obtained by ICR
intercrosses were recovered from the uterus, and Leichert's membrane
was removed. The embryos were cultured with rotation under a
humidiﬁed atmosphere of 5% CO2 at 37 °C in a Falcon tube containing
Dulbecco'smodiﬁedEagle'smediumsupplementedwith 75% rat serum.
In some experiments, embryoswere cultured in the additional presence
of recombinantmouseNodal (R&DSystems) at 50 mg/ml. Alternatively,
the adequate volume of recombinant protein dissolved in culture
medium at 50 mg/ml was injected with the use of a glass needle
(Dramond) and injector (Narishige) into the para-axial mesoderm
immediately below the visceral endoderm layer. Injected embryoswere
incubated for 30 min before theywere ﬁxedwith 4% paraformaldehyde
in PBS overnight at 4 °C.
Results
Asymmetric node enhancer (ANE) confers perinodal L–R asymmetry soon
after the onset of nodal ﬂow
During our analysis of human Lefty genes, we noticed that the 7.5-kb
upstream region of LEFTY1 conferred gene expression in themouse node.
Introduction into fertilized mouse eggs of the hNPE7.5-lacZ transgene, in
which lacZ is linked to the7.5-kbupstreamregionof LEFTY1, thus gave rise
to X-gal staining speciﬁcally in the perinodal crown cells (Fig. 1A and B).
This X-gal staining showed marked L–R asymmetry at E8.2, being
predominant on the left side of the node (Fig. 1B). The expression pattern
of hNPE7.5-lacZ depended on the stage of development, however
(Fig. 1F–I). At E7.5 [the late head-fold (LHF) stage], the transgene was
expressed symmetrically at a low level in the perinodal cells (Fig. 1F).
The level of expression on the left side became greater than that on the
right side thereafter, with LNR asymmetry being obvious at the
one-somite (Fig. 1G), two-somite (Fig. 1H), and four-somite (Fig. 1I)
stages. These results suggested the presence of an asymmetric node
enhancer (ANE) in the 7.5-kb upstream region of LEFTY1.
To localize ANE more precisely, we tested various restriction
fragments derived from the 7.5-kb upstream region of LEFTY1 for the
ability to confer asymmetric expression in theperinodal cells. The1.8-kb
upstream region failed to show such activity (data not shown) (Yashiro
et al., 2000). In contrast, the 1.9-kb Bam-Bg and 1.0-kb BX-Bg fragments
Fig. 1. ANE is an L–R asymmetric node-speciﬁc enhancer. (A) Various restriction fragments of human LEFTY1were linked to lacZ, and the enhancer activity of each fragmentwas examined
in transgenicmouse embryos. The numberof embryos showing LNRexpression ornoexpression (–) of the transgene in thenodeatE8.2 is summarized. The approximate location of FoxH1
binding sites is indicatedby red ovals. Restriction sites: E, EcoRI; Bam, BamHI; BgI, BglI; BX, BstXI; BgII, BglII; Sma, SmaI; Xb, XbaI and Sac, SacI. (B–E) Ventral views ofX-gal-stained embryos
harboring the indicated lacZ transgenes. (F–I) Magniﬁed views of the node region of X-gal-stained embryos harboring hNPE7.5-lacZ. The L–R axis and developmental stage (ps, pairs of
somites) is indicated for each embryo.
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region of LEFTY1 (Fig. 1A, C and D), whereas the 0.8-kb Bam-BgI and
0.5-kb BgI-II fragments had lost it (Fig. 1A). The ANE was then mapped
to the 0.5-kb BgI2 region (Fig. 1A and E), which overlaps with both the
1.9-kb Bam-Bg and 1.0-kb BX-Bg regions. Whereas the 1.8-kb upstream
region of LEFTY1 contains a pair of FoxH1 binding sites (Yashiro et al.,
2000), the 0.5-kb BgI2 region, which possesses ANE activity, does not
include typical FoxH1 binding sites (Fig. 1A). Mouse Lefty1 does not
possess ANE, given that the 10-kb upstream region of the gene (Saijoh
et al., 1999) or a 200-kb region derived from a Lefty1 bacterial artiﬁcial
chromosome (data not shown) did not drive lacZ expression in the
node. Furthermore, we were unable to detect an ANE-like sequence in
mouse Lefty1 that shows substantial similarity to the 0.5-kb BgI2 region
of LEFTY1. ANE therefore appears to be an enhancer that is speciﬁc to
human LEFTY1.
ANE is activated by Nodal signaling independently of FoxH1
To determinewhether ANE activity is regulated by the canonical L–R
pathway, we examined the expression of the hNPE7.5-lacZ transgene invarious L–R mutant mice. Expression of hNPE7.5-lacZ was randomized
in iv/iv embryos; X-gal staining in the perinodal cells was thus either
left-sided (4/15 embryos) (Fig. 2A), right-sided (3/15 embryos)
(Fig. 2B), or bilateral (8/15 embryos) (Fig. 2C and D). In the inv/inv
mutant, on the other hand, hNPE7.5-lacZ expression in the perinodal
cells was either right-sided (11/14 embryos) (Fig. 2E) or bilateral (3/14
embryos) (Fig. 2F). Given that nodal ﬂow is defective in both iv/iv and
inv/inv mutants, these results suggested that ANE activity is under the
control of nodal ﬂow.
We next examined whether ANE activity is regulated by the Nodal
signal.We thus examined expression of hNPE7.5-lacZ in a hypomorphic
Nodalmutant (Nodalneo/neo) that fails to express Nodal in the node and
LPM (Saijoh et al., 2003) aswell as in a Crypticmutant (Yan et al., 1999).
The expression level of hNPE7.5-lacZon the left sidewas reduced in both
Nodalneo/neo (14/14 embryos) (Fig. 2G) and Cryptic−/− (11/11 embryos)
(Fig. 2H)mutants, giving rise to bilateral X-gal staining in the perinodal
cells. These results suggested that ANE is activated in the perinodal cells
on the left side by Nodal signaling.
We also examinedwhether the transcription factor FoxH1 is required
for ANE activity. We crossed mice with a ﬂoxed Foxh1 allele (Yamamoto
Fig. 2. ANE is regulated by Nodal signaling but not by FoxH1. The expression patterns of hNPE7.5-lacZ around the node of the indicated mutant mouse embryos were determined at the
indicated developmental stages. X-gal staining in the node was left-sided (A and I), right-sided (B and E), bilateral (C, D and F), or down-regulated and bilateral (G and H).
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expressed speciﬁcally in perinodal cells (NDE-Cre mice) in order to
generate conditional mutant (Foxh1ﬂox/ﬂox, NDE-Cre) embryos that lack
FoxH1 speciﬁcally in the perinodal cells. NDE-Cre activity is already
evident in crown cells at the early head-fold stage and the one-somite
stage (Suppl. Fig. 1), when crossed with the ROSA26-lacZ reporter mice
(Soriano, 1999). Left-sided expression of hNPE7.5-lacZwasmaintained in
these mutant embryos (Fig. 2I), consistent with the absence of typical
FoxH1 binding sites in the 0.5-kb region of LEFTY1 that possesses ANE
activity. These results thus suggested that ANE is activated on the left side
of the node by FoxH1-independent Nodal signaling.
L–R asymmetric phosphorylation of Smad2/3 in perinodal cells
Our ﬁnding that the L–R asymmetric activity of ANE is regulated by
Nodal signaling suggested that Nodal activity itself may be asymmetric
on the two sides of the node. To examine this possibility, we examined
the distribution of phosphorylated Smad2/3 (pSmad2) in mouse
embryos by immunostaining with speciﬁc antibodies that detect
C-terminal phosphorylation of Smad2 and Smad3. Nodal expression
has been shown to be bilateral in the perinodal cells until the
two-somite stage, and it begins to manifest subtle (LNR) asymmetry
from the three-somite stage (Collignon et al., 1996). In contrast, pSmad2
stainingwas already asymmetric at the LHF stage, being detected in the
perinodal cells exclusively on the posterior-left side (Figs. 3A and A′).
At the two-somite stage, pSmad2 staining was increased in the
perinodal cells on the left side, with a portion of the left LPM adjacent
to the node also being positive for pSmad2 (Fig. 3B and B′). Between the
three- and four-somite stages (Fig. 3C and C′), pSmad2 staining
expanded to include all perinodal cells on the left side and the entire
left LPM. It was also detected in regions where Nodal is not expressed,
including the pit cells on the left side and the prospective ﬂoor plate on
the left side, suggesting that Nodal travels to these regions from the left
LPM or left perinodal cells. Finally, pSmad2 staining had begun todisappear at theﬁve-somite stage (Fig. 3D andD′). This dynamic pattern
of pSmad2 staining thus coincided with that of ANE activity. The
distribution of pSmad2observed inwild-type embryos likely represents
domains where Nodal is active, given that pSmad2 immunoreactivity
was not detected in Nodalneo/neo (Fig. 3J and J′) or Cryptic−/− (Fig. 3K
and K′) embryos.
The pattern of pSmad2 staining in the perinodal cells closely
paralleled that in the LPM. In iv/iv embryos, pSmad2 staining in the
perinodal cells was randomized, being either left-sided (4/14 embryos)
(Fig. 3E and E′), right-sided (4/14 embryos) (Fig. 3F and F′), bilateral at a
high level (4/14 embryos) (Fig. 3G and G′), or bilateral at a low level
(2/14 embryos) (Fig. 3H and H′). In individual iv/iv mutant embryos,
therewas a close relation between thepattern of pSmad2 staining in the
perinodal cells and that in LPM; for example, when pSmad2 staining in
the perinodal cells was left-sided, that in LPMwas also left-sided. Such a
relation was also apparent in inv/inv embryos. Thus, in all ﬁve inv/inv
embryos examined, pSmad2 staining in the perinodal cells was right-
sidedominant and that in LPMwasalso right-sided (Fig. 3I and I′). These
results therefore suggested that asymmetry of Nodal activity in the
perinodal cells is closely related to asymmetry of Nodal expression in
LPM.
Flow-mediated transport of Nodal is not responsible for the asymmetry of
pSmad2 distribution among perinodal cells
Nodal mRNA is distributed symmetrically around the node at the
two-somite stage (Fig. 4A), when pSmad2 distribution is already
asymmetric among the perinodal cells (Fig. 4B). How then does Nodal
signaling become asymmetric if the distribution of Nodal mRNA is
symmetric? If Nodal is secreted into the node cavity where the
leftward ﬂuid ﬂow known as nodal ﬂow exists, then Nodal may be
transported to the left side of the node and give rise to asymmetric
Nodal signaling in the perinodal cells. To test this possibility, we
examined pSmad2 staining in embryos injected with medium
Fig. 3. Asymmetry of pSmad2 distribution around the node correlateswith that in LPM. (A–K) Ventral views of pSmad2 immunostaining inwild-type or the indicatedmutant embryos at
the indicated developmental stages. (A′–K′) The node region of the embryos in (A) through (K), respectively, is shown at higher magniﬁcation. Arrowheads in (A′) and (B′) indicate
pSmad2-positive cells at the node.
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embryos cultured in the presence of recombinant Nodal (Fig. 4E). We
found that pSmad2 staining was apparent ectopically in the right
perinodal cells and para-axial mesoderm (PAM) cells after injection of
embryos with Nodal in the right PAM region (Fig. 4G), whereas
ectopic pSmad2 staining was not seen after injection of medium
(Fig. 4F) or incubation of embryos with excess Nodal in the culture
medium (Fig. 4H). These results thus suggested that, even if Nodal issecreted into the node cavity, it is unable to elicit signaling at the
apical membrane of perinodal cells.
LbR expression of Cerl2 is responsible for the pSmad2/3 asymmetry in
perinodal cells
Cerl2, which encodes a Nodal antagonist, is expressed in the
perinodal cells in an LbR manner (Marques et al., 2004) and was
Fig. 4. Phosphorylation of Smad2/3 in perinodal cells is induced by internally secreted Nodal. (A) In situ hybridization analysis of Nodal mRNA in the node at the two-somite stage.
(B) Immunostaining of pSmad2 at the two-somite stage. (C–E) Experimental protocol. Transverse schematic representations of E8.0 embryos are shown. Sky blue, endoderm; gray,mesoderm;
yellow, ectoderm; red, perinodal cells expressingNodal and pink, recombinantNodal. (F, G) Immunostaining of pSmad2 in embryos thatwere recovered at the three-somite stage, injectedwith
medium (F) or recombinant Nodal (G), and cultured for 30 min before they were ﬁxed with 4% paraform aldehyde. (H) Immunostaining of pSmad2 in an embryo that was recovered at the
three-somite stage and cultured in the presence of recombinant Nodal to the four-somite stage. Arrowheads in (F) through (H) indicate pSmad2-positive cells at the node.
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activity among these cells. To investigate this possibility, we com-
pared the timing of Nodal expression, Cerl2 expression, ANE activity,
and Smad2/3 phosphorylation at the node (Fig. 5). We found that the
expression of Nodalwas bilateral from the early head-fold (EHF) stage
to the one-somite stage (Fig. 5A–C), but that it started to manifest
subtle LNR asymmetry from the two-somite stage (Fig. 5M). ANE
activity was not detected at the EHF (Fig. 5D) and LHF (Fig. 5E) stages
but became manifest at the one-somite stage (Fig. 5F). Immunostain-
ing for pSmad2was not detected at the EHF stage but was apparent on
the posterior-left side of the node at the LHF stage (Fig. 5H) in a small
proportion of the embryos examined (Fig. 5M). Finally, Cerl2 was
previously shown to be expressed asymmetrically around the node by
the LHF stage (Marques et al., 2004). We detected bilateral Cerl2
expression at the EHF stage (Fig. 5J), after which Cerl2 expression on
the left side began to decline, giving rise to an LbR asymmetric
expression pattern among the perinodal cells from the LHF stage
(Fig. 5K and L). Therefore, among the four markers examined, Cerl2
expression and pSmad2 distribution ﬁrst exhibited L–R asymmetry,
followed by ANE activity and Nodal expression. These results thus
supported the notion that LbR asymmetric expression of Cerl2, rather
than asymmetric Nodal expression, is responsible for generation of
LNR asymmetry in Nodal activity among the perinodal cells.
To test this notion directly, we examined Nodal signaling in Cerl2
mutant embryos at E8.2. In Cerl2+/+ embryos, pSmad2 was detected
only on the left side of the node (Fig. 6A and A′). In Cerl2−/− embryos,
pSmad2 staining in the perinodal cells, aswell as that in LPM,was eitherbilateral (2/5 embryos) (Fig. 6B and B′) or bilateral with a subtle LNR
asymmetry (3/5 embryos) (Fig. 6C and C′). Similarly, expression of
hNPE7.5-lacZ was left-sided in wild-type embryos (Fig. 6D), whereas
either bilateral (4/6 embryos) (Fig. 6E) or bilateral with a subtle LNR
asymmetry (2/6 embryos) (Fig. 6F) in Cerl2−/− embryos. Together,
these results suggested that LbR asymmetric expression of Cerl2 is
responsible for LNR asymmetric Nodal activity in the perinodal cells.
Nodal expression, but not Nodal signaling, in perinodal cells is essential
for L–R patterning
The asymmetric distribution of pSmad2 among the perinodal cells
indicated that the level of active Nodal derived from these cells differs
between the L and R sides, whereas the distribution of Nodal mRNA is
symmetric andperinodal cells on the two sides are equally competent to
respond to active Nodal. Active Nodal produced by the perinodal cells
would be expected to act on these cells in an autocrine or paracrine
manner, leading to asymmetry in pSmad2 distribution. However, it
remained unknown whether Nodal signaling in the perinodal cells is
essential for the subsequent development of asymmetry in the LPM.
To address this question, we inhibited Nodal signaling in perinodal
cells with the use either of a dominant negative form of the receptor
ALK4 (dnALK4), which binds to Nodal but does not transduce the Nodal
signal, or of a dominant negative mutant of Smad3 (dnSmad3) that can
inhibit activity of Smad2 and Smad3 (Nakao et al., 1997) (Fig. 7). These
twomutant proteins were each ectopically expressed in perinodal cells
under the control of a perinodal cell-speciﬁc enhancer (NDE) derived
Fig. 5. The ﬁrst L–R asymmetry in perinodal cells is Cerl2 expression. Nodal expression (A–C), hNPE7.5-lacZ expression (ANE activity) (D–F), Smad2/3 phosphorylation (G–I), and Cerl2
expression (J–L) were examined in perinodal cells of mouse embryos at the EHF, LHF, and one-somite stages, respectively. Arrowheads indicate the changes in ANE activity (F), Smad2/3
phosphorylation (H and I) and Cerl2 expression (K and L). (M) Summary of the frequency of embryos that showed L–R asymmetric patterns for each of the fourmarkers examined at the
indicated developmental stages. The number of embryos examined for each marker at each stage ranged from 10 to 17. PS2, pSmad2.
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Fig. 6. LbR asymmetric Cerl2 expression is responsible for the asymmetric pSmad2 distribution among perinodal cells. (A–C) Immunostaining for pSmad2 in wild-type (WT) and
Cerl2−/− embryos, respectively, at the four-somite stage. (A′–C′) Higher magniﬁcation images of the node region of the embryos shown in (A), (B) and (C), respectively. The
distribution of pSmad2 is either bilateral or bilateral with subtle LNR asymmetry in both the node and LPM of the Cerl2mutant. (D–F) Expression of the hNPE7.5-lacZ transgene in
wild-type and Cerl2−/− embryos, respectively, at the indicated developmental stages.
328 A. Kawasumi et al. / Developmental Biology 353 (2011) 321–330from mouse Nodal (Adachi et al., 1999; Norris and Robertson, 1999).
Permanent transgenic lines expressing dnALK4 or dnSmad3 were
successfully established and they did not show developmental defects
(data not shown). Transgenic embryos expressing dnALK4 or dnSmad3
were examined for Nodal expression in LPM at E8.2. In transgenic
embryos expressing dnSmad3, pSmad2 staining in the perinodal cells
was reduced to an undetectable level (Fig. 7E and E') while it was
maintained in the left LPM. In those embryos expressing dnALK4, the
level of pSmad2 staining in the perinodal cells was greatly reduced but
was still detectable (Fig. 7MandM'). Inboth types of transgenic embryo,
left-sided expression of Nodal was maintained in LPM (Fig. 7C and K).
The timing of Nodal expression in LPM did not appear to differ between
the transgenic andnontransgenic embryos (Fig. 7H and P). These results
thus suggested that, although Nodal produced by the perinodal cells is
essential for L–Rpatterningof LPM, autocrine–paracrineNodal signaling
in the perinodal cells themselves does not play a role in this process.
Discussion
Role of ANE in regulation of LEFTY1
We have characterized ANE, which is derived from the human
LEFTY1 gene, as the ﬁrst transcriptional enhancer shown to exhibit L–R
asymmetric activity in the node. Thisﬁnding suggests that LEFTY1might
be expressed in an L–R asymmetric manner in the node of human
embryos. In contrast,mouse Lefty1 is not expressed in theperinodal cells
of themouse embryo, and anANE-like enhancerwas not detected in the
corresponding upstream region ofmouse Lefty1 or of Lefty1 genes of any
other mammal examined (Saijoh et al., 1999) (data not shown).
Whereas expression of a Nodal antagonist (such as Cerl2) on the right
side of the node is thought to be essential for L–R patterning of LPM, aNodal antagonist would not be required on the left side of the node.
Aswehave shown in the present study, Nodal signaling in thenode cells
is dispensable for L–R patterning of LPM. The LEFTY1 gene may be
activated on the left side of the node simply as a response to the
increased Nodal activity. Alternatively, Lefty1 protein expressed on the
left side of the nodemay prevent autocrine Nodal signaling in perinodal
cells of the human embryo.
A typical FoxH1binding sequence, AAT(C/A)(C/A)ACA, is not present
in the 0.5-kb genomic region shown to contain ANE. Although the
consensus Samd2/3 binding sequence, GTCT, is present in this region,
whether this sequence alone is sufﬁcient to confer a response to Nodal
signaling or whether additional transcription factor binding sites are
involved is not known. It will be necessary to dissect ANE and identify
sequence motifs essential for ANE activity in order to clarify this issue.
How is pSmad2 asymmetry induced in the node when Nodal expression is
symmetric?
Nodal produced by perinodal cells would be expected to be secreted
into the node cavity or within the embryo. Although both possibilities
are formally possible, our data suggest that it is Nodal secreted within
the embryo that induces phosphorylation of Smad2/3 and that Smad2/3
is therefore phosphorylated in response to autocrine–paracrine action
of Nodal. This conclusion is further supported by the observed
down-regulation of pSmad2 in the node of embryos lacking the Nodal
coreceptor Cryptic.
We found that pSmad2waspreferentially expressed in theperinodal
cells on the left side even when the distribution of Nodal mRNA is
symmetric. How then is this asymmetry in pSmad2 distribution
generated? Given that ectopic Nodal protein introduced on the right
side of thenode induced Smad2/3phosphorylation on the right side, the
Fig. 7. Asymmetric Nodal signaling inperinodal cells is dispensable for L–Rpatterning of LPM. (A) Schematic representation of the transgene encoding dnSmad3. A node-speciﬁc enhancer
(NDE) is linked to theHsp68 promoter, dnSmad3, an internal ribosome entry site (IRES), and lacZ. (B, C) In situ hybridization analysis ofNodalmRNA in E8.2 nontransgenic (dnSmad3 Tg−)
and dnSmad3 transgenic (dnSmad3 Tg+) mouse embryos, respectively. (D) Expression of the transgene in the dnSmad3 transgenic embryo in (C) was conﬁrmed by in situ hybridization
analysis of lacZmRNA. (E–G) Immunostainingof pSmad2 (E) and beta-galactosidase (F) in anE8.2 embryo that expressed the dnSmad3 transgene. Amerged image is shown in (G). (E′–G′)
Highermagniﬁcation images of the node region of the embryos shown in (E) through (G). (H) Percentage of nontransgenic and dnSmad3 transgenic embryos positive forNodal expression
in LPMat the indicateddevelopmental stages. Thenumber of nontransgenic or transgenic embryos examined at each stage ranged from9 to 15. (I–P) The analyses in (A) through (H)were
repeated with embryos expressing a transgene for dnALK4.
329A. Kawasumi et al. / Developmental Biology 353 (2011) 321–330perinodal cells on both sides are equally competent to respond to active
Nodal. It is therefore most likely that the level of active Nodal derived
from these cells differs between the two sides. The asymmetry in
pSmad2 distribution among the perinodal cells is indirectly controlled
by nodal ﬂow, given that its pattern was inﬂuenced when the ﬂowwas
impaired. However, direct transport of Nodal by the leftward ﬂow is not
likely responsible for the pSmad2 asymmetry, given that ectopic Nodal
protein in the culture medium did not induce ectopic pSmad2 staining
in cultured embryos. Our observations that LbR asymmetric expression
of Cerl2 precedes the asymmetry in pSmad2 distribution and that
pSmad2 is distributed symmetrically in Cerl2−/− embryos suggest that
the major player in induction of pSmad2 asymmetry is Cerl2, a Nodal
antagonist that interacts with Nodal protein and inhibits its activity
(Marques et al., 2004) and whose LbR asymmetric expression among
perinodal cells is controlledby theﬂuidﬂow.AlthoughCerl2may inhibit
Nodal activity through its direct interactionwith Nodal on the right sideof the node, the L–R asymmetry of pSmad2 distribution appears more
pronounced than that of Cerl2 expression, suggesting that other
mechanisms that are ﬂow dependent but independent of Cerl2 may
also contribute to the generation of pSmad2 asymmetry. For instance,
the efﬁciency of Nodal secretion from perinodal cells may differ
between the two sides of the node, possibly being inﬂuenced by
ﬂow-induced intracellular Ca2+ signaling.
RelationbetweenpSmad2asymmetry in theperinodal regionandasymmetry
in LPM
Whereas Nodal expression in perinodal cells is absolutely essential
for L–R asymmetric patterning of LPM, autocrine/paracrine Nodal
signaling in the perinodal cells is dispensable for this process. Therefore,
targets of Nodal protein produced in the node are not perinodal cells but
are most likely LPM cells. Nodal may be transported from the node to
330 A. Kawasumi et al. / Developmental Biology 353 (2011) 321–330LPM via the internal route that includes PAM. Although an asymmetric
distribution of pSmad2 was not detected in PAM, injection of
recombinant Nodal into PAM gave rise to pSmad2 immunostaining in
PAM. PAM may therefore be partially competent to respond to Nodal
signaling (in that it possesses signaling components fromthe receptor to
Smad2/3/4), although it is unable to express Nodal target genes such as
Nodal and Lefty because it lacks FoxH1. Alternatively, the pSmad2
staining induced in PAM may have been an artifact due to the excess
amount of ectopic Nodal injected.
Among L–R mutant mice examined, there was a close correlation
between the asymmetry of pSmad2 distribution among the perinodal
cells and that of Nodal expression in LPM. This similarity was thus
evident in the iv/iv mutant, in which Nodal expression in LPM is
randomized, and in the inv/inv mutant, in which Nodal expression in
LPM is reversed. Given that the level of pSmad2 likely represents the
level of active Nodal derived from the perinodal cells, these results
further support the notion that Nodal produced in the node is
transported to LPM, where it activates Nodal expression via a Nodal-
responsive enhancer (ASE) of the Nodal gene. The LNR asymmetry of
Nodal activity in the node is thus translated into LNR asymmetry of the
amount of Nodal that reaches LPM and subsequently into robust LNR
asymmetry of Nodal expression in LPM through a self-enhancement
lateral inhibition mechanism (Nakamura et al., 2006).
Supplementarymaterials related to this article canbe foundonlineat
doi:10.1016/j.ydbio.2011.03.009.
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